F 0760
Ensure that residents are free from significant medication errors.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
interview and record review, the facility failed to ensure a controlled substance medication was
administered per physician orders. This affected one resident (#21) out of three residents reviewed for
medication administration. This had the potential to affect fifteen residents (#1, #4, #8, #10, #11, #13, #17,
#21, #26, #29, #31, #33, #37, #45, and #47) who were ordered controlled substance medication. The
facility census was 48.
Residents Affected - Few
Findings include:
Review of the medical record for Resident #21 revealed an admission date of 02/03/24. Diagnosis included
acute respiratory failure with hypoxia, chronic diastolic (congestive) heart failure, depression, history of
transient ischemic attack (TIA), chronic obstructive pulmonary disease (COPD), type II diabetes mellitus,
asthma, anxiety disorder, and atrial fibrillation.
Review of the 5-day Minimal Data Set (MDS) assessment dated [DATE] revealed Resident #21 had intact
cognition.
Review of the physician orders dated February 2024 revealed an order for Alprazolam (brand name Xanax)
0.25 milligram (mg) (anti-anxiety medication) give one tablet every twelve hours as needed for anxiety for
fourteen days. Resident #21 did not have an order for Ambien (controlled medication, sedative).
Review of the Resident #21's Medication Administration Records (MAR) for February 2024 revealed on
02/19/24 Xanax 0.25 mg had a blank spot.
Review of the late entry progress note dated 02/19/24 revealed Resident #21 received Zolpidem (Ambien)
5 mg after stating she needed an as needed (PRN) medication.
Interview on 03/12/24 at 6:49 A.M. with Licensed Practical Nurse (LPN) #172 (night nurse) revealed on
02/19/24 she discovered Resident #21 received the wrong medication. LPN #172 reported the resident
received Ambien instead of Alprazolam. LPN #172 reported she notified the physician and Resident #21's
daughter (who is a nurse at the facility - LPN #158). LPN #172 reported LPN #158 (daughter) helped pull
the wrong medication from the starter kit with a second nurse, LPN #164, who administered the Ambien
instead of the ordered Alprazolam.
Interview on 03/12/24 at 8:17 A.M. with LPN #158 revealed Resident #21 was administered Ambien instead
of Alprazolam for anxiety on 02/19/24. (LPN #158 is also the daughter of Resident #21). LPN #158 reported
LPN #164 pulled the wrong medication and she witnessed it. LPN #158 thought Alprazolam was
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
365825
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365825
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/21/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Grande Oaks
24579 Broadway Ave
Oakwood Village, OH 44146
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0760
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
pulled, when she found out later it was Ambien that was pulled from the starter kit. LPN #158 reported LPN
#164 administered the Ambien to Resident #21 instead of Alprazolam.
Interview on 03/14/24 at 8:44 A.M. with Pharmacist #214 revealed she was notified by the Assistant
Director of Nursing (ADON) on 02/20/24 that the wrong medication, Ambien was pulled in error instead of
Xanax. Pharmacist #214 reported once notified on their end, a report was documented, and Ambien
medication was replaced in the starter kit. Pharmacist #214 reported no one from pharmacy needed to
come to the facility since it was self-reported. Pharmacist #214 verified Ambien and Xanax are both
controlled substances, category 4 classification. Ambien is a sedative and Xanax is an antianxiety
medication.
Interview on 03/14/24 at 10:03 A.M. with LPN #164 revealed on 02/19/24 Resident #21 requested Xanax.
LPN #164 reported she had to pull the medication from the starter kit. LPN #164 reported LPN #158 got the
authorization from pharmacy to pull two Alprazolam from the starter kit. LPN #164 reported LPN #158
pulled what they thought was Alprazolam from the starter kit. LPN #164 reported she witnessed and signed
for the medication. LPN #158 reported definitely an error on my part for sure LPN #164 reported she
administered Ambien instead of Alprazolam to Resident #21. LPN #164 reported she was notified by LPN
#172 (night shift nurse) that the wrong medication was pulled. LPN #172 notified LPN #164 they pulled
Ambien from the starter kit and not Alprazolam (as ordered).
Interview on 03/14/24 at 10:49 A.M. with the Director of Nursing (DON) revealed he was notified on
02/19/24 in the evening by LPN #172 regarding Resident #21 administering the wrong medication. The
DON reported Resident #21 was administered Ambien instead of the ordered Xanax. The DON reported he
started an investigation immediately. The DON reported neither LPN #158 nor LPN #164 verified the
correct medication was pulled and administered. The DON reported pharmacy was notified the next day
regarding the medication error and asked to replace the Ambien pulled from the starter kit. The DON
reported education was provided.
Review of the medication error report dated February 19, 2024, at 3:34 P.M. revealed an error without harm
had occurred.
Review of the incident report dated 02/19/24 included inter department team made aware of medication
error with Ambien being administered for anxiety. Authorization to pull Xanax from starter box received from
pharmacy, nurse pulled Zolpidem instead. No negative effects were noted. The incident was reported to
physician. Education was provided to the nurse. The family and resident were notified.
Review of the Request for Removal of Controlled Drug Substances (CDS) Medication From The
Emergency Box/Starter Box revealed authorization from pharmacy was given to pull Alprazolam (Xanax)
0.25 mg, quantity two. Authorization was signed by LPN #158.
This deficiency represents non-compliance investigated under Complaint Number OH00151466.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365825
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365825
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/21/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Grande Oaks
24579 Broadway Ave
Oakwood Village, OH 44146
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0842
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Safeguard resident-identifiable information and/or maintain medical records on each resident that are in
accordance with accepted professional standards.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
record review, interview, and facility policy review the facility failed to ensure a controlled substance was
documented after administered per physician's orders. This affected one resident (#21) out of three
residents reviewed for medication administration. This had the potential to affect fifteen residents (#1, #4,
#8, #10, #11, #13, #17, #21, #26, #29, #31, #33, #37, #45, and #47) who were ordered controlled
substance medication. The facility census was 48.
Findings include:
Review of the medical record for Resident #21 revealed an admission date of 02/03/24. Diagnosis included
acute respiratory failure with hypoxia, chronic diastolic (congestive) heart failure, depression, history of
transient ischemic attack (TIA), chronic obstructive pulmonary disease (COPD), type II diabetes mellitus,
asthma, anxiety disorder, and atrial fibrillation.
Review of the 5-day Minimal Data Set (MDS) assessment dated [DATE] revealed Resident #21 had intact
cognition.
Review of the physician orders dated February 2024 revealed an order for Alprazolam (brand name Xanax)
0.25 milligram (mg) (anti-anxiety medication) give one tablet every twelve hours as needed for anxiety for
fourteen days.
Review of the Resident #21's Medication Administration Records (MAR) for February 2024 revealed for
02/19/24 Xanax 0.25 mg had a blank spot.
Interview on 03/12/24 at 6:49 A.M. with Licensed Practical Nurse (LPN) #172 (night nurse) verified after
medication administration you were to sign off on the MAR that the medication was administered with your
initials.
Interview on 03/12/24 at 8:17 A.M. with LPN #158 verified after medication administration you are to sign
off in the MAR that the medication was administered with your initials. LPN #158 verified Resident #21 (her
mom) received medication.
Interview on 03/14/24 at 10:03 A.M. with LPN #164 verified on 02/19/24 she forgot to sign the MAR after
administering Xanax 0.25 mg to Resident #21. LPN #164 verified she did not sign off the MAR with her
initials because she forgot to do it.
Interview on 03/14/24 at 10:49 A.M. with the Director of Nursing (DON) verified after medication
administration you are to sign off in the MAR the medication was administered with your initials. The DON
verified the medication was not signed off.
Review of the facility policy, Documentation in Medical Record, dated 09/01/22, revealed documentation
shall be completed at the time of service and record date, time of entry, and sign each entry with name and
credentials.
This deficiency was an incidental finding identified during the complaint investigation.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365825
If continuation sheet
Page 3 of 3